These drugs inhibit interleukin (IL)-5, while Dupixent inhibits IL-4 and IL-13, but can be considered a rival because it is also an injection. Patients may opt to take the others because of their ...
Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...
Sanofi’s new atopic dermatitis treatment Dupixent has gained EU approval ... 13 targeting antibody is administered as a subcutaneous injection every other week after an initial loading dose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback